Insulin resistance is a key component of multiple metabolic derangements, which include hypermetabolism, hyperglycemia, increased catabolism, a shift from carbohydrate to fatty acid oxidation, and muscle wasting in burn injury. We have previously shown that impaired IRSI-mediated insuliri signaling occurs after burn injury in skeletal muscle. Reduced expression and increased S/T phosphorylation of IRSI are involved in skeletal muscle insulin resistance of burned mice. After burn injury, expression of protein tyrosine phosphatase-1 B (PTP-1B), which is a negative regulator of insulin receptor/IRSI-mediated signaling, is increased in muscle. FoxOI and 3 genes and their resultant proteins represent evolutionally conserved targets of insulin signaling and regulate metabolism in many tissues including skeletal muscle. Transcriptome analysis of the genomewide expression profile in burn patients indicates that transcriptional activity of FoxOI and 6 is increased in skeletal muscle after burn injury. mRNA expression of target genes of FoxOI and 3 is significantly greater in skeletal muscle of burn patients compared with healthy controls. Consistently, burn injury is associated with decreased phosphorylation of FoxOI and 3 at Akt target sites, and increases in O-glycosylation of FoxOI and MST1 activity in mouse muscle. Therefore, the hypothesis of this project is that IRSI-FoxO dysregulations are key contributors to many if not all of the metabolic derangements of.burn injury and that down-regulation and subsequent nuclear exclusion of FoxOs will improve or eliminate these effects. SA1 will establish the inhibitory effects of burn injury on IRSI-mediated signaling in human skeletal muscle of burn patients and healthy volunteers. SA2 will determine inhibitory and stimulatory phosphorylation, and Oglycosylation of FoxOI and 3 in burn patients and mice and the effects of derangements, insulin signaling, and alterations in gene expression profile in mouse skeletal muscle. SA3 will evaluate the safety and efficacy of PMO knockdown of FoxOI on insulin resistance in skeletal muscle in mice. Rhesus macaques, and healthy volunteers. This project will determine whether FoxOI PMO is a novel potential strategy to reverse insulin resistance and metabolic derangements in skeletal muscle in burn patients.

Public Health Relevance

Metabolic disturbances remain a signficant cause of morbidity and mortality in burn patients. New knowledge gained in this project should promote potential new genomic-based therapeutics to reduce the complications associated with dysregulated metabolism in burn patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM021700-33
Application #
8668970
Study Section
Special Emphasis Panel (ZGM1-PPBC-5)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
33
Fiscal Year
2014
Total Cost
$247,028
Indirect Cost
$103,875
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Zhao, Gaofeng; Yu, Yong-Ming; Kaneki, Masao et al. (2015) Simvastatin reduces burn injury-induced splenic apoptosis via downregulation of the TNF-?/NF-?B pathway. Ann Surg 261:1006-12
Watada, Susumu; Yu, Yong-Ming; Fischman, Alan J et al. (2014) Evaluation of intragastric vs intraperitoneal glucose tolerance tests in the evaluation of insulin resistance in a rodent model of burn injury and glucagon-like polypeptide-1 treatment. J Burn Care Res 35:e66-72
Zhao, Gaofeng; Yu, Yong-Ming; Shoup, Timothy M et al. (2014) Membrane potential-dependent uptake of 18F-triphenylphosphonium--a new voltage sensor as an imaging agent for detecting burn-induced apoptosis. J Surg Res 188:473-9
Carter, Edward A; Paul, Kasie; Bonab, Ali A et al. (2014) Effect of exercise on burn-induced changes in tissue-specific glucose metabolism. J Burn Care Res 35:470-3
Lee, Sangseok; Yang, Hong-Seuk; Sasakawa, Tomoki et al. (2014) Immobilization with atrophy induces de novo expression of neuronal nicotinic *7 acetylcholine receptors in muscle contributing to neurotransmission. Anesthesiology 120:76-85
Fu, Glenn K; Xu, Weihong; Wilhelmy, Julie et al. (2014) Molecular indexing enables quantitative targeted RNA sequencing and reveals poor efficiencies in standard library preparations. Proc Natl Acad Sci U S A 111:1891-6
Khan, Mohammed A S; Sahani, Nita; Neville, Kevin A et al. (2014) Nonsurgically induced disuse muscle atrophy and neuromuscular dysfunction upregulates alpha7 acetylcholine receptors. Can J Physiol Pharmacol 92:1-8
Ueda, Masashi; Iwasaki, Hajime; Wang, Shuxing et al. (2014) Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury. Anesthesiology 121:1311-9
Ibrahim, Amir; Fagan, Shawn; Keaney, Tim et al. (2014) A simple cost-saving measure: 2.5% mafenide acetate solution. J Burn Care Res 35:349-53
Shank, Erik S; Martyn, Jeevendra A; Donelan, Mathias B et al. (2014) Ultrasound-Guided Regional Anesthesia for Pediatric Burn Reconstructive Surgery: A Prospective Study. J Burn Care Res :

Showing the most recent 10 out of 77 publications